- Home
- CLSK vs RGEN Comparison
CLSK vs RGEN Comparison
Compare CLSK & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLSK
- RGEN
- Stock Information
- Founded
- CLSK 1987
- RGEN 1981
- Country
- CLSK United States
- RGEN United States
- Employees
- CLSK N/A
- RGEN N/A
- Industry
- CLSK Finance: Consumer Services
- RGEN Medical/Dental Instruments
- Sector
- CLSK Finance
- RGEN Health Care
- Exchange
- CLSK Nasdaq
- RGEN Nasdaq
- Market Cap
- CLSK 5.7B
- RGEN 6.5B
- IPO Year
- CLSK N/A
- RGEN N/A
- Fundamental
- Price
- CLSK $19.07
- RGEN $166.77
- Analyst Decision
- CLSK Strong Buy
- RGEN Buy
- Analyst Count
- CLSK 10
- RGEN 11
- Target Price
- CLSK $24.36
- RGEN $167.90
- AVG Volume (30 Days)
- CLSK 39.3M
- RGEN 1.1M
- Earning Date
- CLSK 12-01-2025
- RGEN 10-28-2025
- Dividend Yield
- CLSK N/A
- RGEN N/A
- EPS Growth
- CLSK N/A
- RGEN N/A
- EPS
- CLSK 0.98
- RGEN N/A
- Revenue
- CLSK $631,937,000.00
- RGEN $673,956,000.00
- Revenue This Year
- CLSK $111.04
- RGEN $16.77
- Revenue Next Year
- CLSK $42.29
- RGEN $13.79
- P/E Ratio
- CLSK $19.73
- RGEN N/A
- Revenue Growth
- CLSK 84.66
- RGEN 8.73
- 52 Week Low
- CLSK $6.45
- RGEN $102.97
- 52 Week High
- CLSK $23.61
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- CLSK 56.95
- RGEN 75.11
- Support Level
- CLSK $16.23
- RGEN $155.74
- Resistance Level
- CLSK $22.69
- RGEN $165.11
- Average True Range (ATR)
- CLSK 2.07
- RGEN 5.73
- MACD
- CLSK -0.43
- RGEN 1.06
- Stochastic Oscillator
- CLSK 38.19
- RGEN 88.26
About CLSK CleanSpark Inc.
Cleanspark Inc is a bitcoin mining company. Through CleanSpark, Inc., and the Company's wholly owned subsidiaries, the company mines bitcoin. The company entered the bitcoin mining industry through its acquisition of ATL. Bitcoin mining is the sole reportable segment of the company.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.